New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer – News-Medical.Net

Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies,…

Click here to view the original article.